Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar 11;19(3):e3000890.
doi: 10.1371/journal.pbio.3000890. eCollection 2021 Mar.

Towards precision medicine in diabetes? A critical review of glucotypes

Adam Hulman  1 , Yuri D Foreman  2   3 , Martijn C G J Brouwers  2   3 , Abraham A Kroon  2   3 , Koen D Reesink  3 , Pieter C Dagnelie  2   3 , Carla J H van der Kallen  2   3 , Marleen M J van Greevenbroek  2   3 , Kristine Færch  4   5 , Dorte Vistisen  4 , Marit E Jørgensen  4   6 , Coen D A Stehouwer  2   3 , Daniel R Witte  1   7
Affiliations
Comment

Towards precision medicine in diabetes? A critical review of glucotypes

Adam Hulman et al. PLoS Biol. .

Abstract

In response to a study previously published in PLOS Biology, this Formal Comment thoroughly examines the concept of 'glucotypes' with regard to its generalisability, interpretability and relationship to more traditional measures used to describe data from continuous glucose monitoring.

Trial registration: ClinicalTrials.gov NCT02695810.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interest exists.

Figures

Fig 1
Fig 1. Example CGM profiles of participants in the PRE-D Trial with corresponding proportion of time spent in different glucotypes and conventional measures (mean and CV).
CGM, continuous glucose monitoring; CV, coefficient of variation.
Fig 2
Fig 2
Observed proportion of time spent in the 3 glucotypes by mean CGM glucose (A) and coefficient of variation (B) in The Maastricht Study, and by mean CGM glucose in the PRE-D Trial (C) alongside predicted proportions based on the regression analysis in The Maastricht Study. CGM, continuous glucose monitoring.
See this image and copyright information in PMC

Comment in

Comment on

  • Glucotypes reveal new patterns of glucose dysregulation.
    Hall H, Perelman D, Breschi A, Limcaoco P, Kellogg R, McLaughlin T, Snyder M. Hall H, et al. PLoS Biol. 2018 Jul 24;16(7):e2005143. doi: 10.1371/journal.pbio.2005143. eCollection 2018 Jul. PLoS Biol. 2018. PMID: 30040822 Free PMC article.

References

    1. Fitipaldi H, McCarthy MI, Florez JC, Franks PW. A global overview of precision medicine in type 2 diabetes. Diabetes. 2018;67:1911–22. 10.2337/dbi17-0045 - DOI - PMC - PubMed
    1. Ahlqvist E, Storm P, Käräjämäki A, Martinell M, Dorkhan M, Carlsson A, et al.. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361–9. 10.1016/S2213-8587(18)30051-2 - DOI - PubMed
    1. Hall H, Perelman D, Breschi A, Limcaoco P, Kellogg R, McLaughlin T, et al.. Glucotypes reveal new patterns of glucose dysregulation. PLoS Biol. 2018;16:e2005143. 10.1371/journal.pbio.2005143 - DOI - PMC - PubMed
    1. Hulman A, Witte DR, Vistisen D, Balkau B, Dekker JM, Herder C, et al.. Pathophysiological characteristics underlying different glucose response curves: A latent class trajectory analysis from the prospective EGIR-RISC Study. Diabetes Care. 2018;41:1740–8. 10.2337/dc18-0279 - DOI - PubMed
    1. Zaccardi F, Khunti K. Glucose dysregulation phenotypes—time to improve outcomes. Nat Rev Endocrinol. 2018;14:632–3. 10.1038/s41574-018-0092-3 - DOI - PubMed

Publication types

Associated data